Select Publications

Journal articles

Wright E; Brew BJ; Wesselingh S, 2008, 'Pathogenesis and diagnosis of viral infections of the nervous system', Neurologic Clinics, 26, pp. 617 - 617

Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati T; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh S, 2008, 'Response to Birbeck et al', Epilepsia, 49, pp. 541 - 543

Maneglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors', British Journal of Pharmacology, 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80

Ting KK; Brew BJ; Guillemin GJ, 2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, 12, pp. 247 - 262

Pemberton LA; Stone E; Price P; van Bockxmeer FM; Brew BJ, 2008, 'The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia', HIV Medicine, 9, pp. 677 - 680

Batmanian JJ; Lam M; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', Medical Journal of Australia, 188, pp. 489 - 490, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256113000019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2007, 'AIDS dementia complex', Handbook of Clinical Neurology, 85, pp. 79 - 91, http://dx.doi.org/10.1016/S0072-9752(07)85006-8

Cinque P; Brew BJ; Gisslen M; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex', Handbook of Clinical Neurology, 85, pp. 261 - 300, http://dx.doi.org/10.1016/S0072-9752(07)85017-2

Brew BJ, 2007, 'Neurological sequelae of primary HIV infection', Handbook of Clinical Neurology, 85, pp. 69 - 77, http://dx.doi.org/10.1016/S0072-9752(07)85005-6

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-saharan Africa - Reply from the editorialists', NEUROLOGY, 69, pp. 412 - 413, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248243300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brew BJ; Gonzalez-Scarano F, 2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa [7]', Neurology, 69, pp. 412 - 413, http://dx.doi.org/10.1212/01.wnl.0000278073.28318.66

Batmanian JJ; Lam MK; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, 187, pp. 567 - 570

Mellgren A; Price R; Hagberg L; Rosengren L; Brew BJ; Gisslen M, 2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection', Neurology, 69 (15), pp. 1536 - 1541

Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, 27, pp. 12884 - 12892

Guillemin GJ; Cullen K; Lim C; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, 27, pp. 12884 - 12892

Lim CK; Smythe GA; Stocker R; Brew BJ; Guillemin GJ, 2007, 'Characterization of the kynurenine pathway in primary human oligodendrocytes', International Congress Series, 1304, pp. 213 - 217

Guillemin GJ; Brew BJ, 2007, 'Chronic HIV infection leads to an Alzheimer’s disease like illness - Involvement of the kynurenine pathway', International Congress Series, 1304, pp. 324 - 334

Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment', HIV Medicine, 8, pp. 192 - 202

Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price R; Rosengren L; Gisslen M, 2007, 'CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration', Journal of Neurology, 254, pp. 1026 - 1032

Gisslen M; Hagberg L; Rosengren L; Brew BJ; Cinque P; Spudich S; Price R, 2007, 'Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2, pp. 112 - 119

Ting KK; Brew BJ; Guillemin GJ, 2007, 'Effect of Quinolinic acid on gene expression in human Astrocytes: Implications on Alzheimer’s disease', International Congress Series, 1304, pp. 384 - 388

Gisslen M; Hagberg L; Brew BJ; Cinque P; Price R; Rosengren L, 2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex', Journal of Infectious Diseases, 195, pp. 1774 - 1778

Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson H; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; Mc Arthur J; Symonds W; Romero C, 2007, 'Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial', PLoS Clinical Trials, 2

Brew BJ, 2007, 'HAD and the need for new trial design methodology', AIDS, 21, pp. 1965 - 1966

Brew BJ; Gonzalez-Scarano F, 2007, 'HIV-associated dementia - An inconvenient truth', Neurology, 68, pp. 324 - 325

Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, 14, pp. 418 - 423

Croitoru-Lamoury J; Lamoury F; Zaunders J; Veas LA; Brew BJ, 2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone', Journal of Interferon and Cytokine Research, 27, pp. 53 - 64

Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, 8, pp. 520 - 528

Brew BJ, 2007, 'Lost in translation: Again, another failed neuroprotection trial', Neurology, 69, pp. 1308 - 1309

Guillemin GJ; Brew BJ; Noonan C; Knight TG; Cullen K, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques', International Congress Series, 1304, pp. 404 - 408

Gorry P; Mcphee D; Verity E; Dyer W; Wesselingh S; Learmont J; Sullivan JS; Roche M; Zaunders J; Gabuzda D; Crowe S; Mills J; Lewin S; Brew BJ; Cunningham AL; Churchill M, 2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo', Retrovirology, 4 (66)

Ting KK; Brew BJ; Guillemin GJ, 2007, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, 12, pp. 247 - 262

Antinori A; Arendt G; Becker J; Brew BJ; Byrd D; Cherner M; Clifford D; Cinque P; Epstein L; Goodkin K; Gisslen M; Grant I; Heaton R; Joseph JE; Marder K; Marra C; McArthur J; Nunn M; Price R; Pulliam L; Robertson K; Sacktor N; Valcour V; Wojna V, 2007, 'Updated research nosology for HIV-associated neurocognitive disorders', Neurology, 69, pp. 1789 - 1799

Brew B, 2006, 'Relativity and relativism', NEW SCIENTIST, 188, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234329300034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DFJ; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR, 2006, 'Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia', Journal of NeuroVirology, 12, pp. 219 - 228, http://dx.doi.org/10.1080/13550280600827369

Shah M; Smit T; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena N, 2006, 'Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage', AIDS Research and Human Retroviruses, 22, pp. 177 - 181

Guillemin GJ; Meininger V; Brew BJ, 2006, 'Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis (Review)', Neurodegenerative Diseases, 2, pp. 166 - 176

Croitoru-Lamoury J; Williams K; Lamoury F; Veas LA; Ajami B; Taylor R; Brew BJ, 2006, 'Neural transplantation of human MSC and NT2 cells in the twitcher mouse model', Cytotherapy, 8, pp. 445 - 458

Cysique LA; Maruff P; Darby D; Brew BJ, 2006, 'The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery', Archives of Clinical Neuropsychology, 21, pp. 185 - 194

Cysique LA; Maruff P; Brew BJ, 2006, 'The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis', Journal of the International Neuropsychological Society, 12, pp. 368 - 382

Lamoury F; Croitoru-Lamoury J; Brew BJ, 2006, 'Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1', Cytotherapy, 8, pp. 228 - 242

Cysique LA; Maruff P; Brew BJ, 2006, 'Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study', BMC NEUROLOGY, 6, pp. 42 - 42

Cysique LA; Maruff P; Brew BJ, 2006, 'Variable benefit in neuropsychological function in HIV-infected HAART-treated patients', Neurology, 66, pp. 1447 - 1450

Brew B, 2005, 'Relativity and relativism [9]', New Scientist, 188, pp. 27

Guillemin GJ; Cullen KM; Smythe GA; Brew BJ, 2005, 'Involvement of the kynurenine pathway in neuroinflammation', INFLAMMATION RESEARCH, 54, pp. S199 - S199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe G; Callen KM, 2005, 'Mass spectroscopic detection of quinolinic acid in microdissected Alzheimer's disease plaques', INFLAMMATION RESEARCH, 54, pp. S200 - S200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600374&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex', Journal of Neuroinflammation, 2, http://dx.doi.org/10.1186/1742-2094-2-16

Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, 10, pp. 16 - 21

Brew BJ, 2005, 'HIV and the nervous system - palliative carte aspects', Journal of the Neurological Sciences, 238, pp. S38 - S38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brew BJ, 2005, 'HIV associated neurology in the developing world', Journal of the Neurological Sciences, 238, pp. S22 - S22, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088000089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a


Back to profile page